Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1149-1155

  Aoki, Motonori ^a,b   Fukunaga, Masahiro ^a   Kitagawa, Minetake ^a   Hayashi, Kazumi ^a   Morokata, Tatsuaki ^a   Ishikawa, Go ^a   Kubo, Satoshi ^a   Yamada, Toshimitsu ^a  

^a Inst for Drug Discovery Research   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE; ANTIINFLAMMATORY AGENT; INTERLEUKIN 5; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR; PREDNISOLONE; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME INHIBITION; EOSINOPHILIA; FERRET; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; VOMITING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILIA; EOSINOPHILS; FERRETS; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED C57BL; PHOSPHODIESTERASE INHIBITORS; PREDNISOLONE; PYRIDINES; PYRIMIDINONES; RATS; RATS, INBRED BN; ROLIPRAM;

EID: 0033680091     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Microvascular permeability and number of tight junctions are modulated by cAMP
2. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chiorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity
3. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation
4. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma
5. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992
6. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4
7. In vitro pharmacology of the novel phosphodlesterase type 4 inhibitor, CP-80633
8. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV-selective PDE inhibitors
9. 3H]rolipram binding activity and their relationship to emetic behavior in the ferret
10. The therapeutic potential of PDE4 inhibitors
11. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression
12. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor
13. Effect of prolonged repeated exposure to ovalbumin in sensitized Brown Norway rats
14. The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects
15. Eosinophils: Role in asthma, allergy and parasite immunity
16. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects
17. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B
18. Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors
19. Apoptosis of eosinophils and lymphocytes in allergic inflammation
20. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1
21. Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram
22. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai
23. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: Comparison with rolipram
24. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodlesterases
25. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children
26. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity
27. 2. Implications for the therapeutic use of beta-adrenoceptor agonists
28. Inhibition of antigen-induced bconchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram
29. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity
30. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor
31. Results of a phase II study of the antidepressant effect of rolipram